Grantmaking public charityEIN 510306704
Clayton Medical Research Foundation Inc
Carson City, NV 89703
Total Assets
$100.0M
FY 2024
Annual Giving
$2.5M
FY 2024
Grants Made
2
FY 2024
Avg Grant
$1.3M
FY 2024
Grant Range
—
Typical
Deadlines
—
Applications
Programs & Activities
Program 1
$579KThe Novel Biologically Active Peptides and Small Proteins grant to the Salk Institute for Biological Studies funds research. The overreaching hypothesis of this project is that novel drug targets exist among the thousands of newly discovered microproteins. The list includes uncharacterized secreted bioactive peptides and small proteins. In the past two years the focus has shifted from intracellular microproteins to uncharacterized secreted bioactive peptides because they are similar to peptide hormones and neuropeptides, which have proven expellant drug targets. Consequently, this project has three aims: the deep characterization of C4ORF48 in neurobiology and Alzheimer's disease (Aim 1), the role of augurin in metabolic health and cancer (Aim 2), and the continued identification of novel peptides to feed into this pipeline (Aim 3). As part of these broader efforts, tools have been developed for this project, such as ShortStop, to find and characterize these novel bioactive peptides.
Program 2
$496KThe MorfVeuss Discovery, Screening and Therapeutic Platform grant to the Salk Institute for Biological Studies funds research to develop a screening platform, called MorfVeuss, that will allow the discovery of micro-peptide drug targets while transforming these discoveries into gene and oncolytic viral therapeutic candidates. The objective of this platform is to overcome a critical unmet need in identifying and characterizing a novel class of therapeutics, building from very recent discoveries in the past decade in the emerging field of micro-proteins. Development of this platform should open the door for new breakthroughs and a pipeline of innovative new drug candidates, applicable across different indications.
Program 3
$438KThe Foundation funded 2 other medical research grants and project administration expenses at The Salk Institute for Biological Studies. The titles of the 2 additional grants are as follows: (1) Identification of functional markers for developing side effect-free non-opioid analgesics
Program 4
$348K(2) Bifunctional Small Molecules for Rapid Protein Clearance from Blood
Financial Snapshot
2024 filing
Total Revenue
$5.2M
Total Expenses
$3.1M
Giving Over Time
4 years
Total dollars recorded per filing year. Scale adjusts to the foundation's range.
Top Recipients
11 grants
Grant Size Distribution
11 grants
Geographic Focus
1 states
Ready to work on a proposal for Clayton Medical Research Foundation Inc?
Open a draft with this funder pre-selected. Add guidelines when you have them.
Related funders in Nevada
THE TERRANCE K AND ELIZABETH L BARRY
LAS VEGAS, NV · $2.9M in grants
LUDDY CHARITABLE FOUNDATION
LAS VEGAS, NV · $2.6M in grants
KJS FAMILY FOUNDATION
LAS VEGAS, NV · $1.3M in grants
Jacob L and Lillian
Reno, NV · $1M in grants
E C FULLER TRUST U ART 16 MAIN
LAS VEGAS, NV · $950K in grants
HOLDEEN TEN FUNDS (47-10)
LAS VEGAS, NV · $850K in grants
THE CARINE AND JACQUES DUBOIS
LAS VEGAS, NV · $575K in grants
LOUIS PLANSOEN FDN CO-TTEE
LAS VEGAS, NV · $560K in grants
Track Clayton Medical Research Foundation Inc
Get an email when Grantivo has new data for Clayton Medical Research Foundation Inc, such as a fresh IRS filing, updated financials, or newly reported grants. No account needed.
Free. Unsubscribe anytime. Or create an account to draft an application.